Intercept Pharma pulls liver disease drug from US after regulator's request – Reuters

1. Intercept Pharma pulls liver disease drug from US after regulator’s request  Reuters
2. Intercept Voluntarily Withdraws Obeticholic Acid (Ocaliva) for PBC From US Market  HCP Live
3. Intercept pulls liver disease drug from market as FDA puts clinical trials on hold  Endpoints News
4. Intercept pulls Ocaliva from US market after FDA request  FirstWord Pharma
5. Intercept, after many setbacks, pulls liver disease drug Ocaliva in US  Fierce Pharma

Continue Reading